Developer docs
API playgroundTry for free, no card

Search company profiles

The Feinstein Institutes

Full company profile

uuid0002yiz

Namestring
The Feinstein Institutes
Legal namestring
The Feinstein Institutes for Medical Research
Company typeenum
Private
Founded yearint
1999
Descriptiontext

The Feinstein Institutes for Medical Research is the nonprofit research division of Northwell Health, New York's largest healthcare provider. Operating 50 research labs and conducting 3,000-5,000 active clinical research studies with approximately 6,300 researchers and staff, the institute is organized around six specialized research institutes covering behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. It is recognized as the global scientific leader in bioelectronic medicine, a field that uses electronic devices — particularly vagus nerve stimulation — to treat inflammatory and stress-related diseases as an alternative to pharmaceutical intervention.

The institute's core scientific platforms include the FDA-approved SetPoint System for rheumatoid arthritis (co-developed by Feinstein CEO Dr. Kevin J. Tracey through SetPoint Medical), novel peptide drug candidates (P2-1 for sepsis and rheumatoid arthritis; NDI for sepsis-induced acute lung injury), the eCIRP/MFG-E8 inflammation research program, ultrasound-based neuromodulation for obesity (in collaboration with GE Research), and proprietary discoveries in brain circuit control of inflammation and stress. Education and training are delivered through the Elmezzi Graduate School of Molecular Medicine, MD/PhD programs with Cold Spring Harbor Laboratory and the Zucker School of Medicine, and a Summer Student Intern Program. The institute also publishes two peer-reviewed journals (Molecular Medicine and Bioelectronic Medicine) and administers the annual Ross Prize in Molecular Medicine and Cerami Award in Translational Medicine.

Revenue is generated through a hybrid nonprofit model: NIH and federal research grants (including disclosed awards of $6.1M for red cell disorders, $3M from NINDS, and $1.8M MSTP training grant), institutional support from parent Northwell Health, philanthropy, educational program tuition, and technology licensing (e.g., SetPoint Medical). Primary stakeholders are patients participating in clinical trials, physician-scientist trainees, collaborating academic institutions, and federal funders. The institute holds 17 patents associated with its senior scientific leadership and has published over 500 peer-reviewed articles, with Dr. Ping Wang recognized as the second-most-cited sepsis scientist globally.

Short descriptiontext

The Feinstein Institutes for Medical Research is the nonprofit research division of Northwell Health, operating 50 labs and 3,000-5,000 clinical studies with 6,300 researchers. It is the global leader in bioelectronic medicine, advancing vagus nerve stimulation and molecular medicine for sepsis, cancer, autoimmune, and inflammatory diseases.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersManhasset, United States
HQ citystring
Manhasset
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioelectronic medicine research, clinical research studies, medical research institutes, translational medicine research, molecular medicine research
Industry3 codes
1Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryYes
2Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryNo
3Health & Biomedical Research Universities (Academic Medical Center–Affiliated)
CodeEDAHABACPrimaryNo
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Medical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1NIH Research Grants
TypeOthers
Description

Primary funding source from National Institutes of Health grants for specific research projects including red cell disorders ($6.1M, 7-year grant), physician scientist training ($1.8M, 5-year MTSP grant), and various R01 grants for sepsis, radiation research, and other inflammatory conditions.

businesswire.com
2Northwell Health Institutional Support
TypeOthers
Description

Operational and strategic support from parent organization Northwell Health, the largest health care provider in New York.

feinstein.northwell.edu
3Educational Programs
TypeProfessional Services
Description

Revenue from educational programs including the Elmezzi Graduate School of Molecular Medicine, summer student internship programs, and visiting scientist programs.

feinstein.northwell.edu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, New York's largest healthcare provider. It conducts basic, translational, and clinical research across six specialized institutes covering bioelectronic medicine, molecular medicine, cancer, behavioral science, health system science, and translational research. It runs 50 research labs and 3,000-5,000 clinical research studies, and offers graduate-level education programs including the Elmezzi Graduate School of Molecular Medicine and physician-scientist training.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Discovery of brain circuit linking inflammation and stress response, published in Journal of Experimental Medicine
+5 more records
Product overview1 text field

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, New York's largest healthcare provider. It is organized around six specialized research institutes covering behavioral science, bioelectronic medicine, cancer research, health system science, molecular medicine, and translational research. The organization operates 50 research labs conducting over 5,000 clinical research studies with 6,300 researchers and staff. Key offerings include advanced medical education programs (Elmezzi Graduate School, Summer Intern Program, Visiting Scientists Program), peer-reviewed journals (Molecular Medicine, Bioelectronic Medicine), prestigious awards (Ross Prize, Cerami Award), and digital health platforms including the MyNorthwell patient portal. The institutes are the global scientific leader in bioelectronic medicine, pioneering vagus nerve stimulation therapies including the FDA-approved SetPoint System for rheumatoid arthritis.

Product and service6 records
1Elmezzi Graduate School of Molecular Medicine
CategoryEducation Program
Description

PhD program for physicians seeking careers in biomedical research, training students to discover causes of human diseases and translate research into diagnostic and therapeutic solutions.

2Summer Student Intern Program
CategoryEducation Program
Description

Mentored program providing undergraduate students with hands-on experience in disease-oriented research, including workshops, seminars and academic poster presentation.

3Visiting Scientists & Scholars Program
CategoryEducation Program
Description

Program allowing scientists and students to volunteer in research programs under mentorship of Feinstein faculty researchers.

4Medical Marvels Program
CategoryEducation Program
Description

Collaborative research competition for Long Island high school students (grades 9-10) encouraging STEM career pathways, established by Feinstein Institutes and Center for Workforce Readiness.

5Molecular Medicine Journal
CategoryPublication
Description

Peer-reviewed, open-access journal published by Feinstein Institutes achieving all-time high impact factor, recognizing outstanding biomedical research.

6Bioelectronic Medicine Journal
CategoryPublication
Description

Peer-reviewed journal published in collaboration with BMC/Springer Nature covering the emerging field of bioelectronic medicine and neural modulation therapies.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Biotech company co-founded by Dr. Kevin J. Tracey that developed the SetPoint System, an implantable vagus nerve stimulation device for rheumatoid arthritis. The FDA-approved device was implanted at Northwell's North Shore University Hospital in August 2025 as the nation's first such implantation.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-03-03
Description

Collaboration between Feinstein Institutes and GE Research to demonstrate ultrasound stimulation as a noninvasive treatment for obesity. GE provided novel ultrasound technology for peripheral nerve modulation, while Feinstein researchers conducted preclinical studies showing therapeutic effects on body weight, food intake, and metabolic markers. Research published in Scientific Reports.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership where Zucker School of Medicine MD/PhD students can conduct PhD research at Cold Spring Harbor Laboratory, home to eight Nobel Prize winners. Students benefit from state-of-the-art facilities and collaboration with renowned scientists in cancer, neuroscience, plant biology, and quantitative biology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The Zucker School of Medicine is built on established medical education programs of Northwell Health and robust research conducted at the Feinstein Institutes. Students have opportunities to complete MD/PhD portions of their degree at Feinstein Institutes or partner institutions.

Strategic tierCoreTypeOthers
Description

The Feinstein Institutes is the research arm of Northwell Health, New York's largest health care provider. This parent-subsidiary relationship provides institutional support, clinical trial infrastructure, and access to patient populations across the health system's facilities in New York, Hudson Valley, and western Connecticut.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Feinstein Institutes

Medical Research Servicesfeinstein.northwell.edu

The Feinstein Institutes for Medical Research is the nonprofit research division of Northwell Health, operating 50 labs and 3,000-5,000 clinical studies with 6,300 researchers. It is the global leader in bioelectronic medicine, advancing vagus nerve stimulation and molecular medicine for sepsis, cancer, autoimmune, and inflammatory diseases.

What The Feinstein Institutes does

The Feinstein Institutes for Medical Research is the nonprofit research division of Northwell Health, New York's largest healthcare provider. Operating 50 research labs and conducting 3,000-5,000 active clinical research studies with approximately 6,300 researchers and staff, the institute is organized around six specialized research institutes covering behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. It is recognized as the global scientific leader in bioelectronic medicine, a field that uses electronic devices — particularly vagus nerve stimulation — to treat inflammatory and stress-related diseases as an alternative to pharmaceutical intervention.

The institute's core scientific platforms include the FDA-approved SetPoint System for rheumatoid arthritis (co-developed by Feinstein CEO Dr. Kevin J. Tracey through SetPoint Medical), novel peptide drug candidates (P2-1 for sepsis and rheumatoid arthritis; NDI for sepsis-induced acute lung injury), the eCIRP/MFG-E8 inflammation research program, ultrasound-based neuromodulation for obesity (in collaboration with GE Research), and proprietary discoveries in brain circuit control of inflammation and stress. Education and training are delivered through the Elmezzi Graduate School of Molecular Medicine, MD/PhD programs with Cold Spring Harbor Laboratory and the Zucker School of Medicine, and a Summer Student Intern Program. The institute also publishes two peer-reviewed journals (Molecular Medicine and Bioelectronic Medicine) and administers the annual Ross Prize in Molecular Medicine and Cerami Award in Translational Medicine.

Revenue is generated through a hybrid nonprofit model: NIH and federal research grants (including disclosed awards of $6.1M for red cell disorders, $3M from NINDS, and $1.8M MSTP training grant), institutional support from parent Northwell Health, philanthropy, educational program tuition, and technology licensing (e.g., SetPoint Medical). Primary stakeholders are patients participating in clinical trials, physician-scientist trainees, collaborating academic institutions, and federal funders. The institute holds 17 patents associated with its senior scientific leadership and has published over 500 peer-reviewed articles, with Dr. Ping Wang recognized as the second-most-cited sepsis scientist globally.

The Feinstein Institutes firmographics

Firmographics
Name
The Feinstein Institutes
Legal name
The Feinstein Institutes for Medical Research
Website
https://feinstein.northwell.edu
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The Feinstein Institutes for Medical Research is the nonprofit research division of Northwell Health, operating 50 labs and 3,000-5,000 clinical studies with 6,300 researchers. It is the global leader in bioelectronic medicine, advancing vagus nerve stimulation and molecular medicine for sepsis, cancer, autoimmune, and inflammatory diseases.
Ownership category
akta.pro rank

The Feinstein Institutes industry classification

Industry
Product category
Medical Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro primary industry
Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
akta.pro secondary industries
Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC)

Keywords

  • Bioelectronic medicine research
  • Clinical research studies
  • Medical research institutes
  • Translational medicine research
  • Molecular medicine research

Where The Feinstein Institutes is headquartered

Location

Headquarters

HQ city
Manhasset
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The Feinstein Institutes business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. NIH Research Grants: Primary funding source from National Institutes of Health grants for specific research projects including red cell disorders ($6.1M, 7-year grant), physician scientist training ($1.8M, 5-year MTSP grant), and various R01 grants for sepsis, radiation research, and other inflammatory conditions.
  2. Northwell Health Institutional Support: Operational and strategic support from parent organization Northwell Health, the largest health care provider in New York.
  3. Educational Programs: Revenue from educational programs including the Elmezzi Graduate School of Molecular Medicine, summer student internship programs, and visiting scientist programs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

The Feinstein Institutes product offering

Product offering

Core offering

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, New York's largest healthcare provider. It conducts basic, translational, and clinical research across six specialized institutes covering bioelectronic medicine, molecular medicine, cancer, behavioral science, health system science, and translational research. It runs 50 research labs and 3,000-5,000 clinical research studies, and offers graduate-level education programs including the Elmezzi Graduate School of Molecular Medicine and physician-scientist training.

Product overview

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, New York's largest healthcare provider. It is organized around six specialized research institutes covering behavioral science, bioelectronic medicine, cancer research, health system science, molecular medicine, and translational research. The organization operates 50 research labs conducting over 5,000 clinical research studies with 6,300 researchers and staff. Key offerings include advanced medical education programs (Elmezzi Graduate School, Summer Intern Program, Visiting Scientists Program), peer-reviewed journals (Molecular Medicine, Bioelectronic Medicine), prestigious awards (Ross Prize, Cerami Award), and digital health platforms including the MyNorthwell patient portal. The institutes are the global scientific leader in bioelectronic medicine, pioneering vagus nerve stimulation therapies including the FDA-approved SetPoint System for rheumatoid arthritis.

Differentiator

Problem solved

Functional benefit

Products and services

  • Elmezzi Graduate School of Molecular Medicine PhD program for physicians seeking careers in biomedical research, training students to discover causes of human diseases and translate research into diagnostic and therapeutic solutions.
  • Summer Student Intern Program Mentored program providing undergraduate students with hands-on experience in disease-oriented research, including workshops, seminars and academic poster presentation.
  • Visiting Scientists & Scholars Program Program allowing scientists and students to volunteer in research programs under mentorship of Feinstein faculty researchers.
  • Medical Marvels Program Collaborative research competition for Long Island high school students (grades 9-10) encouraging STEM career pathways, established by Feinstein Institutes and Center for Workforce Readiness.
  • Molecular Medicine Journal Peer-reviewed, open-access journal published by Feinstein Institutes achieving all-time high impact factor, recognizing outstanding biomedical research.
  • Bioelectronic Medicine Journal Peer-reviewed journal published in collaboration with BMC/Springer Nature covering the emerging field of bioelectronic medicine and neural modulation therapies.

Quantifiable outcome

  • Discovery of brain circuit linking inflammation and stress response, published in Journal of Experimental Medicine
  • +5 more outcomes

Companies that use The Feinstein Institutes

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

The Feinstein Institutes technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature5 records

The Feinstein Institutes partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • SetPoint MedicalcoreStrategic or Co-development Partner · 21 January 2026Biotech company co-founded by Dr. Kevin J. Tracey that developed the SetPoint System, an implantable vagus nerve stimulation device for rheumatoid arthritis. The FDA-approved device was implanted at Northwell's North Shore University Hospital in August 2025 as the nation's first such implantation.
  • GE ResearchcoreStrategic or Co-development Partner · 3 March 2021Collaboration between Feinstein Institutes and GE Research to demonstrate ultrasound stimulation as a noninvasive treatment for obesity. GE provided novel ultrasound technology for peripheral nerve modulation, while Feinstein researchers conducted preclinical studies showing therapeutic effects on body weight, food intake, and metabolic markers. Research published in Scientific Reports.
  • Cold Spring Harbor LaboratorycoreStrategic or Co-development PartnerStrategic partnership where Zucker School of Medicine MD/PhD students can conduct PhD research at Cold Spring Harbor Laboratory, home to eight Nobel Prize winners. Students benefit from state-of-the-art facilities and collaboration with renowned scientists in cancer, neuroscience, plant biology, and quantitative biology.
  • Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellcoreStrategic or Co-development PartnerThe Zucker School of Medicine is built on established medical education programs of Northwell Health and robust research conducted at the Feinstein Institutes. Students have opportunities to complete MD/PhD portions of their degree at Feinstein Institutes or partner institutions.
  • Northwell HealthcoreOthersThe Feinstein Institutes is the research arm of Northwell Health, New York's largest health care provider. This parent-subsidiary relationship provides institutional support, clinical trial infrastructure, and access to patient populations across the health system's facilities in New York, Hudson Valley, and western Connecticut.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

The Feinstein Institutes competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

The Feinstein Institutes social profiles

Digital presence

The Feinstein Institutes financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Feinstein Institutes leadership team

Management profile

Number of profiles

Profiles12 records

The Feinstein Institutes funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Feinstein Institutes M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Feinstein Institutes

What does The Feinstein Institutes do?

The Feinstein Institutes for Medical Research is the research arm of Northwell Health, New York's largest healthcare provider. It conducts basic, translational, and clinical research across six specialized institutes covering bioelectronic medicine, molecular medicine, cancer, behavioral science, health system science, and translational research. It runs 50 research labs and 3,000-5,000 clinical research studies, and offers graduate-level education programs including the Elmezzi Graduate School of Molecular Medicine and physician-scientist training.

Is The Feinstein Institutes a public or private company?

The Feinstein Institutes is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The Feinstein Institutes founded?

The Feinstein Institutes was founded in 1999. It employs 5,001 to 10,000 people.

Where is The Feinstein Institutes based?

The Feinstein Institutes is headquartered in Manhasset, United States, in the North America region.

How does The Feinstein Institutes make money?

Three revenue lines are on record. NIH Research Grants are the primary driver. The others are northwell Health Institutional Support and educational Programs.

Does The Feinstein Institutes have an API?

No public API is recorded for The Feinstein Institutes.

What industry is The Feinstein Institutes in?

The Feinstein Institutes's product category is Medical Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NorthwellFeinstein Institutes awarded $8.9M for care planning program in older adults and those with dementiaThe Feinstein Institutes awarded $8.9M for the AEGIS care planning program targeting older adults and those with dementia. The program uses video education and trained educators to guide family conversations about care preferences. The trial aims to improve quality of life and alleviate healthcare burdens.ScienceMajor highway of the human nervous system gets a complete road mapScientists at the Feinstein Institutes for Medical Research have created the first comprehensive anatomical map of the human vagus nerve, analyzing 30 sets of cadaver nerves using ultrasound imaging, micro-CT scanning, and antibody staining to trace thousands of individual nerve fibers from the brain stem to all major organs. The map, now available on the SPARC platform, could help doctors more precisely stimulate the vagus nerve to treat conditions such as epilepsy, stroke, and inflammatory diseases. Researchers say the baseline map may explain variability in patient responses to existing vagus nerve stimulation therapies, potentially enabling more personalized and effective treatments.FinancialContent Business PageFeinstein Summer Concert raises $3.5 million to advance groundbreaking medical researchThe 21st annual Feinstein Summer Concert, held on July 23 at Old Westbury Gardens, raised $3.5 million for the Feinstein Institutes for Medical Research, bringing the event's cumulative fundraising total to nearly $50 million since inception. The fundraiser supports discoveries across the institutes' six research areas, including bioelectronic medicine where the FDA has approved a device pioneered at the institutes, and where Northwell Health became the first U.S. health system to implant the device in a rheumatoid arthritis patient. The event featured a performance by indie pop band AJR and was emceed for the 10th consecutive year by Chris Wragge of CBS News New York.Today on MedscapeNovel Neuromodulation Restores Movement After ParalysisResearchers from the Feinstein Institutes for Medical Research utilized a double neural bypass neuroprosthesis to restore hand movement and sensation in a patient with complete tetraplegia. The AI-powered system, which links brain implants to spinal cord stimulation, enabled the patient to regain functional abilities such as self-feeding and grasping objects while promoting lasting neuroplasticity. Following these successful results, the team has received FDA approval to expand trial sizes and is testing the technology on stroke patients.Business Wire BlogFeinstein Institutes 2026 Ross Prize awarded to Drs. Michel Sadelain and Carl H. JuneThe Feinstein Institutes for Medical Research has selected Drs. Carl H. June and Michel Sadelain to receive the 13th annual Ross Prize in Molecular Medicine for their pioneering work developing CAR T-cell therapy for cancer treatment. The prize, which includes a $50,000 award and will be presented on June 11 in New York City in conjunction with The New York Academy of Sciences, recognizes their foundational research that led to the first FDA-approved cell and gene therapy in 2017. Both researchers continue to advance CAR-T therapies for broader cancer applications and other diseases.MorningstarFeinstein Institutes 2026 Ross Prize awarded to Drs. Michel Sadelain and Carl H. JuneThe Feinstein Institutes for Medical Research has selected Dr. Carl H. June of the University of Pennsylvania and Dr. Michel Sadelain of Columbia University to receive the 13th annual Ross Prize in Molecular Medicine, to be presented on June 11, 2026 in New York City. The award recognizes their pioneering work developing CAR T-cell therapy for cancer treatment, which led to the first FDA-approved cell and gene therapy in 2017. The prize, administered in conjunction with The New York Academy of Sciences and including a $50,000 award, is presented annually to investigators whose research shows high potential for transforming disease treatment.GenomeWebRADx Tech Awards Feinstein Institutes $500K to Accelerate Endometriosis Assay DevelopmentThe Feinstein Institutes for Medical Research received a $500,000 award from the US Department of Health and Human Services' RADx Tech group to advance development of a non-invasive endometriosis biomarker test using menstrual samples. The ROSE study has enrolled over 3,700 participants and uses single-cell RNA sequencing to identify altered cells shed monthly during menstruation, aiming to replace the current invasive surgical diagnostic method. The research team is working toward US Food and Drug Administration approval of the diagnostic test.BioSpaceFeinstein Institutes’ Scientists Discover Brain Circuit That Links Inflammation and Stress ResponseScientists at the Feinstein Institutes for Medical Research discovered a specific brain circuit that acts as a control center for both inflammation and stress responses, with findings published in the Journal of Experimental Medicine. The study identified neurons producing corticotropin-releasing hormone that are activated by inflammatory molecules and psychological stress, and showed that removing these neurons protected against inflammation and stress-induced heart rate changes. This discovery supports the concept of an "immune engram" and advances bioelectronic medicine approaches that could treat inflammatory and stress-related conditions through neural circuit targeting.Business Wire BlogFeinstein Institutes’ Researchers Develop Promising Therapeutic for Sepsis-Induced Acute Lung InjuryScientists at Northwell Health’s Feinstein Institutes for Medical Research developed a promising therapeutic for sepsis-induced acute lung injury (ALI). They identified a specific subset of neutrophils, DLL4+ neutrophils, that drive lung damage, and designed a therapy using a Notch1-DLL4 inhibitor that improved survival in animal models.Business Wire BlogFeinstein Institutes Awarded $4M Grant to Develop AI-Powered Speech Based ‘Vital Signs’ to Improve Psychosis Diagnosis and TreatmentThe Feinstein Institutes for Medical Research received a $4 million grant from the National Institute of Mental Health to develop AI-powered speech analysis tools for measuring psychosis severity. The project, led by Dr. Sunny Tang, aims to create personalized metrics that allow clinicians to predict mental health episodes and intervene sooner using data from patient speech samples. This initiative seeks to provide objective, low-cost markers for illness severity in mental health care.